Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacc.2018.05.028 | DOI Listing |
Patient Prefer Adherence
July 2015
Vitartis Medizin-Service GmbH, Göttingen, Germany.
Purpose: Multiple sclerosis (MS) is a chronic demyelinating, degenerative disease requiring long-term treatment. Patient adherence to treatment may be challenging in such scenarios, especially since treatment often involves self-injection, for example, with interferon beta-1b during therapy. BETACONNECT™ is a novel electronic autoinjector for patient support in interferon beta-1b administration.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!